AU2001282414A1 - Identifying antigen clusters for monitoring a global state of an immune system - Google Patents

Identifying antigen clusters for monitoring a global state of an immune system

Info

Publication number
AU2001282414A1
AU2001282414A1 AU2001282414A AU8241401A AU2001282414A1 AU 2001282414 A1 AU2001282414 A1 AU 2001282414A1 AU 2001282414 A AU2001282414 A AU 2001282414A AU 8241401 A AU8241401 A AU 8241401A AU 2001282414 A1 AU2001282414 A1 AU 2001282414A1
Authority
AU
Australia
Prior art keywords
binding moieties
antigens
disease
clustering
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001282414A
Other languages
English (en)
Inventor
Irun R. Cohen
Eytan Domany
Gad Getz
Guy Hed
Fransisco J. Quintana
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Publication of AU2001282414A1 publication Critical patent/AU2001282414A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30—Unsupervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Hematology (AREA)
  • Data Mining & Analysis (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Evolutionary Biology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioethics (AREA)
  • Software Systems (AREA)
  • Public Health (AREA)
  • Evolutionary Computation (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
AU2001282414A 2000-07-24 2001-07-18 Identifying antigen clusters for monitoring a global state of an immune system Abandoned AU2001282414A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL137460 2000-07-24
IL13746000A IL137460A0 (en) 2000-07-24 2000-07-24 Identifying antigen clusters for monitoring a global state of an immune system
PCT/IL2001/000660 WO2002008755A2 (fr) 2000-07-24 2001-07-18 Identification de groupes d'antigenes permettant de controler l'etat general d'un systeme immunitaire

Publications (1)

Publication Number Publication Date
AU2001282414A1 true AU2001282414A1 (en) 2002-02-05

Family

ID=11074431

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001282414A Abandoned AU2001282414A1 (en) 2000-07-24 2001-07-18 Identifying antigen clusters for monitoring a global state of an immune system

Country Status (6)

Country Link
US (6) US20040014069A1 (fr)
EP (1) EP1368775A2 (fr)
AU (1) AU2001282414A1 (fr)
CA (1) CA2418217A1 (fr)
IL (3) IL137460A0 (fr)
WO (1) WO2002008755A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL137460A0 (en) * 2000-07-24 2001-07-24 Yeda Res & Dev Identifying antigen clusters for monitoring a global state of an immune system
US8460243B2 (en) * 2003-06-10 2013-06-11 Abbott Diabetes Care Inc. Glucose measuring module and insulin pump combination
US7722536B2 (en) * 2003-07-15 2010-05-25 Abbott Diabetes Care Inc. Glucose measuring device integrated into a holster for a personal area network device
US20050260770A1 (en) * 2004-04-01 2005-11-24 Cohen Irun R Antigen array and diagnostic uses thereof
CA2858901C (fr) 2004-06-04 2024-01-16 Carolyn Anderson Architecture hote-client de soins pour le diabete et systemes de gestion de donnees
AU2009315230A1 (en) 2008-11-12 2010-05-20 The Brigham And Women's Hospital, Inc. Diagnosis of multiple sclerosis
WO2011041531A1 (fr) 2009-09-30 2011-04-07 Abbott Diabetes Care Inc. Interconnexion pour dispositif de surveillance de substance à analyser sur un corps
AU2011213923A1 (en) 2010-02-12 2012-08-30 Tel Hashomer Medical Research Infrastructure And Services Ltd. Diagnosis of systemic lupus erythematosus (SLE)
WO2012050828A2 (fr) * 2010-09-29 2012-04-19 Janssen Biotech, Inc. Marqueurs sériques pour l'identification de sujets atteints de sclérodermie généralisée
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US8652999B1 (en) 2012-07-24 2014-02-18 Dow Agrosciences, Llc. Herbicidal compositions comprising 4-amino-3-chloro-5-fluoro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acid or a derivative thereof and a sulfonylaminocarbonyltriazolinone
JP2017503169A (ja) 2013-12-31 2017-01-26 イエダ・リサーチ・アンド・デベロツプメント・カンパニー・リミテツド オリゴヌクレオチド抗原を使用する全身性エリテマトーデスの診断
WO2015101987A1 (fr) 2013-12-31 2015-07-09 Yeda Research And Development Co. Ltd. Méthode de dosage d'une compétence immunologique
WO2016139659A1 (fr) 2015-03-01 2016-09-09 Immunarray Ltd. Diagnostic du lupus érythémateux systémique à l'aide d'antigènes protéiques, peptidiques et oligonucléotidiques
TW201939514A (zh) * 2018-03-16 2019-10-01 日商弘泰生物科技股份有限公司 免疫實體之有效率的分群
JP6500144B1 (ja) * 2018-03-28 2019-04-10 Ｋｏｔａｉバイオテクノロジーズ株式会社 免疫実体の効率的クラスタリング
CN112259219B (zh) * 2020-09-30 2024-02-02 吾征智能技术(北京)有限公司 一种基于上消化道出血预测疾病的系统、设备、存储介质

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE567682A (fr) 1957-12-07
IL36670A (en) * 1971-04-21 1974-09-10 Sela M Therapeutic basic copolymers of amino acids
US5840836A (en) * 1989-02-17 1998-11-24 Bayer Corporation Pancreatic islet cell antigens obtained by molecular cloning
US5578303A (en) * 1989-03-14 1996-11-26 Yeda Research And Development Co. Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus
US5780034A (en) * 1989-03-14 1998-07-14 Yeda Research And Development Co. Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus using heat shock protein determinents
US5114844A (en) 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus
US6897287B1 (en) * 1990-01-31 2005-05-24 Oklahoma Medical Research Foundation Ro/SSA peptide reagents for diagnosis of autoantibodies
US5326357A (en) * 1992-03-18 1994-07-05 Mount Sinai Hospital Corporation Reconstituted cartridge tissue
IL113812A (en) * 1994-05-24 2000-06-29 Yeda Res & Dev Copolymer-1 pharmaceutical compositions containing it and its use
US5585069A (en) * 1994-11-10 1996-12-17 David Sarnoff Research Center, Inc. Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis
US5763158A (en) * 1997-02-06 1998-06-09 The United States Of America As Represented By The Secretary Of The Army Detection of multiple antigens or antibodies
EP1051624A4 (fr) * 1998-01-29 2002-05-02 Glaucus Proteomics B V Series haute densite pour l'analyse des proteomes et procedes et compositions pour ces derniers
IL137460A0 (en) 2000-07-24 2001-07-24 Yeda Res & Dev Identifying antigen clusters for monitoring a global state of an immune system
CA2443777A1 (fr) * 2001-04-10 2002-10-24 The Board Of Trustees Of The Leland Stanford Junior University Utilisation therapeutique et diagnostique de profils de specificite d'anticorps
US20050260770A1 (en) * 2004-04-01 2005-11-24 Cohen Irun R Antigen array and diagnostic uses thereof

Also Published As

Publication number Publication date
EP1368775A2 (fr) 2003-12-10
US20090258790A1 (en) 2009-10-15
WO2002008755A2 (fr) 2002-01-31
IL210570A (en) 2012-10-31
US10082503B2 (en) 2018-09-25
US20040014069A1 (en) 2004-01-22
IL137460A0 (en) 2001-07-24
WO2002008755A3 (fr) 2003-09-12
US20110301065A1 (en) 2011-12-08
IL210570A0 (en) 2011-03-31
IL153832A (en) 2011-02-28
US20140200159A1 (en) 2014-07-17
US11002735B2 (en) 2021-05-11
US20200225223A1 (en) 2020-07-16
US8703654B2 (en) 2014-04-22
CA2418217A1 (fr) 2002-01-31
US8010298B2 (en) 2011-08-30
US20190004045A1 (en) 2019-01-03

Similar Documents

Publication Publication Date Title
US11002735B2 (en) Identifying antigen clusters for monitoring a global state of an immune system
US20200256861A1 (en) Immunosignaturing: a path to early diagnosis and health monitoring
Hueber et al. Antigen microarray profiling of autoantibodies in rheumatoid arthritis
RU2276790C2 (ru) Микроанализ на аллергены
WO2006091734A9 (fr) Compositions et procedes de classification d'echantillons biologiques
Lueking et al. Profiling of alopecia areata autoantigens based on protein microarray technology
US20110275537A1 (en) Method of biological and medical diagnostics using immune patterns obtained with arrays of peptide probes
JP2007534086A (ja) 全身性自己免疫疾患の診断のためのパターン認識方法
US20220341930A1 (en) Diagnostic to distinguish bacterial infections
US9410965B2 (en) Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual
US10126300B2 (en) Immunosignature based diagnosis and characterization of canine lymphoma
CN116635950A (zh) 样本定量分析的改进或与样本定量分析相关的改进
EP1327148A2 (fr) Procede de reconnaissance de formes permettant le diagnostic de maladies auto-immunes systemiques
EP3622291A1 (fr) Biomarqueurs de diagnostic pour la détection, le sous-typage et/ou l'évaluation de la progression de la sclérose en plaques
Lubomirski et al. A consolidated approach to analyzing data from high-throughput protein microarrays with an application to immune response profiling in humans
US20210388345A1 (en) Profiling of rheumatoid arthritis autoantibody repertoire and peptide classifiers therefor
Weiner et al. Diagnosis of multiple sclerosis
WO2024026413A2 (fr) Détection précoce et surveillance de maladies neurodégénératives à l'aide d'une plateforme de diagnostic à maladies multiples
Elizur Antigen Chip: Development and analysis; An application to autoimmune diseases
CONSIGLIERE et al. Immune Response Profiling with Protein Microarrays for Autoantibodies Characterization as Biomarkers: Applications in Stroke and Human African Trypanosomiasis

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application